Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penson

Showing results (711-720 of 1,177) with videos related to

Pageof 118
Sort By:
European Urology|January 21, 2014
Overdiagnosis and overtreatment of prostate cancerStacy Loeb, Marc A Bjurlin, Joseph Nicholson, et al.
Neurourology and Urodynamics|March 8, 2017
Urinary retention and catheter use among U.S. female Medicare beneficiaries: Prevalence and risk factorsJoshua A Cohn, Shenghua Ni, Melissa R Kaufman, et al.
The Journal of Urology|August 12, 2005
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trialRuth D Etzioni, Nadia Howlader, Pamela A Shaw, et al.
American Journal of Epidemiology|February 12, 2008
Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialAlan R Kristal, Kathryn B Arnold, Jeannette M Schenk, et al.
Acta Neuropathologica Communications|October 19, 2018
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutationsErik A Williams, Julie J Miller, Shilpa S Tummala, et al.
The British Journal of Surgery|December 1, 1994
Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinomaM S Highley, F X Parnis, G A Trotter, et al.
Urology|March 15, 2001
Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE databaseD F Penson, W H Schonfeld, S C Flanders, et al.
Journal of the National Cancer Institute|September 16, 2004
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes studyArnold L Potosky, William W Davis, Richard M Hoffman, et al.
Journal of the National Cancer Institute|September 8, 2005
Prostate cancer and the Will Rogers phenomenonPeter C Albertsen, James A Hanley, George H Barrows, et al.
American Journal of Epidemiology|November 25, 2004
An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United StatesPamela A Shaw, Ruth Etzioni, Steven B Zeliadt, et al.
Pageof 118

Showing results (711-720 of 1,177) with videos related to

Sort By:
Pageof 118
European Urology|January 21, 2014
Overdiagnosis and overtreatment of prostate cancerStacy Loeb, Marc A Bjurlin, Joseph Nicholson, et al.
Neurourology and Urodynamics|March 8, 2017
Urinary retention and catheter use among U.S. female Medicare beneficiaries: Prevalence and risk factorsJoshua A Cohn, Shenghua Ni, Melissa R Kaufman, et al.
The Journal of Urology|August 12, 2005
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trialRuth D Etzioni, Nadia Howlader, Pamela A Shaw, et al.
American Journal of Epidemiology|February 12, 2008
Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialAlan R Kristal, Kathryn B Arnold, Jeannette M Schenk, et al.
Acta Neuropathologica Communications|October 19, 2018
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutationsErik A Williams, Julie J Miller, Shilpa S Tummala, et al.
The British Journal of Surgery|December 1, 1994
Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinomaM S Highley, F X Parnis, G A Trotter, et al.
Urology|March 15, 2001
Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE databaseD F Penson, W H Schonfeld, S C Flanders, et al.
Journal of the National Cancer Institute|September 16, 2004
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes studyArnold L Potosky, William W Davis, Richard M Hoffman, et al.
Journal of the National Cancer Institute|September 8, 2005
Prostate cancer and the Will Rogers phenomenonPeter C Albertsen, James A Hanley, George H Barrows, et al.
American Journal of Epidemiology|November 25, 2004
An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United StatesPamela A Shaw, Ruth Etzioni, Steven B Zeliadt, et al.
Pageof 118